n.molnar
Submits third-party assay reports on material purchased directly. Based in Oulu.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
8
n=8
Annotations
0
n=0
Median purity submitted
99.06%
n=8
Suppliers covered
7
n=8
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041472 | PT-141 (Bremelanotide) | QYB | QYB-2607-L4875 | PeptideMeter | 2026-Q3 | 99.93 | 3.94 | — | Buyer-sourced | 0 | PASS |
| AX-2026-041933 | IGF-1 LR3 | SinoPep | SNP-2606-D4620 | Janoshik | 2026-Q3 | 98.55 | 5.56 | 91.2 | Buyer-sourced | 0 | PASS |
| AX-2026-042548 | GHRP-2 | HJ | HJ-2602-W6219 | Janoshik | 2026-Q2 | 99.18 | 1.31 | 91.3 | Buyer-sourced | 0 | PASS |
| AX-2026-041883 | Semaglutide | SinoPep | SNP-2511-P4283 | Medutest | 2026-Q2 | 98.25 | 3.96 | — | Buyer-sourced | 0 | PASS |
| AX-2026-041227 | Tirzepatide | WWB | WWB-2511-J1983 | Janoshik | 2026-Q1 | 99.04 | 4.26 | 103.6 | Buyer-sourced | 0 | PASS |
| AX-2025-019539 | CJC-1295 (no DAC) | TFC | TFC-2507-C9225 | Janoshik | 2025-Q4 | 99.09 | 6.30 | — | Buyer-sourced | 0 | PASS |
| AX-2025-019036 | BPC-157 | ASY | ASY-{CAT}-2719 | Janoshik | 2025-Q4 | 99.60 | 5.47 | 96.3 | Buyer-sourced | 0 | PASS |
| AX-2025-021067 | BPC-157 | BCH | BCH-2508-H4066 | Nordanalyt | 2025-Q4 | 98.58 | 4.19 | 104.3 | Buyer-sourced | 1 | FAIL |